Rice Hall James & Associates’s Covetrus, Inc. Common Stock CVET Stock Holding History

Rice Hall James & Associates’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-123,334	Closed	-$2.56M	–	277
2022 Q2	$2.56M	Sell	123,334 -4,129	-3%	-$73.5K	0.12%	169
2022 Q1	$2.14M	Sell	127,463 -2,452	-2%	-$42.9K	0.09%	205
2021 Q4	$2.59M	Sell	129,915 -1,972	-1%	-$37.1K	0.09%	194
2021 Q3	$2.39M	Buy	131,887 +17,887	+16%	+$410K	0.09%	178
2021 Q2	$3.08M	Sell	114,000 -37,050	-25%	-$1.04M	0.11%	140
2021 Q1	$4.53M	Sell	151,050 -2,138	-1%	-$72.9K	0.15%	119
2020 Q4	$4.4M	Sell	153,188 -54,174	-26%	-$1.46M	0.15%	109
2020 Q3	$5.06M	Sell	207,362 -121,382	-37%	-$2.62M	0.2%	95
2020 Q2	$5.88M	Buy	+328,744	New	+$4.32M	0.25%	106

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rice Hall James & Associates's CVET Position: Q3 2022 in Review

Rice Hall James & Associates sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 123,334 shares — an estimated $2.56M sold.

Rice Hall James & Associates first reported a position in CVET in Q2 2020 and held it in 9 quarters. The position peaked at $5.88M in Q2 2020. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

Rice Hall James & Associates reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Rice Hall James & Associates sold 123,334 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $2.56M.
Rice Hall James & Associates first reported a position in Covetrus, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
Rice Hall James & Associates's Covetrus, Inc. Common Stock position peaked at $5.88M in Q2 2020.
250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.